米国市場銘柄情報

AMGN アムジェン

銘柄追加

310.085
+31.695+11.39%

取引中 05/03 15:46 ET

1,663.22億時価総額44.30直近PER

アムジェンに関するコメント

ログインコメントを投稿

Kevin Travers

3 時間前

コラムFinally Friday, Finally May. Higher Unemployment? Investors say 'Buy Now' | Market Moovers

Morning mooers! It is Friday, May 3rd, and the market green after a jam-packed Q1 earnings week.
This time around, FOMC nonaction and low jobs numbers helped push equities in the green, or it migh just be because April is finally over. My name is Kevin Travers, here are stories moving the market:
MOOVERS
$Amgen (AMGN.US)$'s stock soared 12% toward biggest gain in 15 years, adding more than 220 points to the...

TanKH

4 時間前

Short term trade

$アムジェン(AMGN.US)$
It has been a while since I last traded.
3 days effort. Thank you Amgen

Share Your Today's Profit/Loss

Movers and Shakers

6 時間前

コラムToday's Morning Movers and Top Ratings: AAPL, AMGN, SQ, NET and More

Morning Movers
Gapping up
$アップル(AAPL.US)$ rose by 7% after the company reported a decline in revenue in the first quarter of the year but still exceeded analysts' projections. The tech giant also announced a $110 billion stock buyback program and raised its dividend by 4%.
$アムジェン(AMGN.US)$ soared by 13% after the company expressed encouragement upon completing an interim analysis of its mid-stage study of the weight-loss drug M...

Moomoo Breakfast US

6 時間前

コラムMorning News Call | Dow Futures Jump 500 Points as Weak Jobs Report Sends Yields Lower

Friday, May 3
Before the Bell U.S.
Stock futures jumped sharply Friday after a softer-than-expected April jobs report boosted hopes that the Federal Reserve could start cutting interest rates soon.
Futures tied to the $NYダウ(.DJI.US)$ gained 502 points, or 1.3%. $S&P 500 Index(.SPX.US)$ futures rose 1.1%, while $NASDAQ 100 Index(.NDX.US)$ futures advanced about 1.6%.
Top News
U.S. Job Gro...

nerdbull1669

14 時間前

Market Optimistic Amid Uncertainty Over Rate Cut Decision

We saw yesterday’s trading session maintaining a positive tone from start to finish, gaining momentum in the afternoon.
The Dow Jones Industrial Average saw an increase of 0.9%, while the S&P 500 also rose by 0.9%. The Nasdaq Composite experienced a more significant boost, climbing 1.5%, and the Russell 2000 outperformed with a 1.8% increase.
We have Coinbase and Block releasing their earnings after hours and they lead the earnings surpris...

Big Tech Stocks Diverge: Will they boost the market again?

life is a blessing

04/12 10:50

ESPR is the Probably the Most Undervalued Stock on the Market, Offers 2500% Upside. 2 FDA Approved Blockbuster Drugs. Billions in Sales Expected. Buyout Expected.

$エスペリオン・セラピューティクス(ESPR.US)$ Esperion (ESPR) stock price has dropped from a recent high of $3.40 a share to $2.31 on FALSE claims of dilution. The price drop offers an amazing buying opportunity.
Huge News On Mar 25.2024 U.S. FDA Approved Broad Labels for NEXLIZET and NEXLETOL, now regular doctors can prescribe and Insurance will...

Carla Lee

04/01 22:31

what is your best undervalued stocks?

Investors subscribing to the value investing approach believe it's possible to identify stocks that are trading at a price below their intrinsic value. The idea is that, by investing in these companies before the market corrects, one stands to experience gains when the price of the stock increases to match the true value.
For March 2024, the most undervalued stocks—those with the lowest price-to-earnings (P/E) ratios for each sector—include energy transportat...

PREMOSULTRAA

03/08 11:47

OBESITY Will only focus on main players $VKTX $LLY $NVO $AMGN $GPCR

$バイキング・セラピューティクス(VKTX.US)$$イーライリリー(LLY.US)$$ノボ・ノルディスク(NVO.US)$$アムジェン(AMGN.US)$$Structure Therapeutics Inc(GPCR.US)$
Demand is too high for the obesity drugs but major drug companies unable to keep up with this demand. This will be an opportunity for multiple drug companies to take a pie out of the obesity market.
SubQ likely to be prescribed first for short term weight loss and oral drugs for maintenance. This is not an oncology space ...

Moomoo AI

03/01 02:50

Disney, Fox Corp-B, and Warner Bros Discovery's joint venture faces a lawsuit by FuboTV on antitrust grounds. Amgen's weak performance is due to mixed financial forecasts and questions about its weight-loss drug, MariTide. Constellation Energy's strong performance is backed by the IRA's nuclear production tax credit and effective cash flow deployment. Charter Communications' poor performance is due to a surprise loss in internet subscribers and missed quarterly earnings expectations.